ZWJ Investment Counsel Inc. Has $216,000 Holdings in The Clorox Company $CLX

ZWJ Investment Counsel Inc. lessened its position in shares of The Clorox Company (NYSE:CLX) by 6.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,800 shares of the company’s stock after selling 118 shares during the quarter. ZWJ Investment Counsel Inc.’s holdings in Clorox were worth $216,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Precedent Wealth Partners LLC grew its holdings in shares of Clorox by 20.0% during the 2nd quarter. Precedent Wealth Partners LLC now owns 11,303 shares of the company’s stock worth $1,357,000 after purchasing an additional 1,881 shares in the last quarter. Stock Yards Bank & Trust Co. grew its holdings in shares of Clorox by 1.4% during the 2nd quarter. Stock Yards Bank & Trust Co. now owns 21,423 shares of the company’s stock worth $2,572,000 after purchasing an additional 300 shares in the last quarter. Ameritas Advisory Services LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $48,000. Exchange Capital Management Inc. grew its holdings in shares of Clorox by 11.2% during the 2nd quarter. Exchange Capital Management Inc. now owns 10,871 shares of the company’s stock worth $1,305,000 after purchasing an additional 1,095 shares in the last quarter. Finally, Hilltop National Bank acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $322,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the topic of several recent analyst reports. TD Cowen decreased their price target on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research note on Wednesday. Jefferies Financial Group decreased their price target on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Morgan Stanley decreased their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. JPMorgan Chase & Co. boosted their price target on Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research note on Monday, September 8th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Clorox in a research note on Saturday, September 27th. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $134.08.

Clorox Trading Up 0.9%

CLX stock opened at $123.30 on Friday. The company has a market cap of $15.08 billion, a P/E ratio of 18.91, a PEG ratio of 0.99 and a beta of 0.52. The Clorox Company has a twelve month low of $116.53 and a twelve month high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The business has a fifty day moving average of $122.81 and a 200-day moving average of $129.53.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox’s payout ratio is presently 76.07%.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.